Equities researchers at Goldman Sachs Group started coverage on shares of Molina Healthcare (NYSE:MOH) in a research note issued to investors on Wednesday, January 3rd, Marketbeat reports. The brokerage set a “neutral” rating and a $83.00 price target on the stock. Goldman Sachs Group’s target price points to a potential downside of 9.58% from the stock’s current price.

Other research analysts have also recently issued research reports about the company. Wolfe Research upgraded Molina Healthcare from a “market perform” rating to an “outperform” rating in a research note on Monday, October 23rd. Zacks Investment Research upgraded Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $88.00 price objective on the stock in a research note on Tuesday, January 2nd. Morgan Stanley boosted their price objective on Molina Healthcare from $68.00 to $89.00 and gave the stock an “overweight” rating in a research note on Friday, November 3rd. Raymond James Financial reiterated a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Finally, Jefferies Group boosted their price target on Molina Healthcare from $64.00 to $74.00 and gave the stock a “hold” rating in a research note on Friday, November 3rd. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $70.86.

How to Become a New Pot Stock Millionaire

Shares of Molina Healthcare (NYSE:MOH) opened at $91.79 on Wednesday. Molina Healthcare has a 1 year low of $42.56 and a 1 year high of $93.98. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market capitalization of $5,270.00, a price-to-earnings ratio of -17.42, a PEG ratio of 1.08 and a beta of 0.97.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The firm had revenue of $5.03 billion for the quarter, compared to analysts’ expectations of $4.95 billion. During the same period last year, the firm posted $0.85 EPS. Molina Healthcare’s revenue was up 10.7% on a year-over-year basis. analysts expect that Molina Healthcare will post -3.88 EPS for the current year.

In other news, Director John C. Molina sold 16,226 shares of the company’s stock in a transaction that occurred on Thursday, January 18th. The stock was sold at an average price of $92.49, for a total transaction of $1,500,742.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Terry Bayer sold 9,077 shares of the stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $77.45, for a total value of $703,013.65. Following the completion of the transaction, the chief operating officer now directly owns 74,478 shares of the company’s stock, valued at $5,768,321.10. The disclosure for this sale can be found here. Insiders have sold 785,275 shares of company stock valued at $61,862,491 over the last ninety days. Corporate insiders own 6.20% of the company’s stock.

A number of hedge funds have recently modified their holdings of MOH. Schwab Charles Investment Management Inc. grew its holdings in Molina Healthcare by 11.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 349,366 shares of the company’s stock worth $24,170,000 after buying an additional 36,454 shares in the last quarter. Legal & General Group Plc lifted its position in Molina Healthcare by 8.5% in the second quarter. Legal & General Group Plc now owns 56,863 shares of the company’s stock worth $3,936,000 after purchasing an additional 4,462 shares during the period. Comerica Bank lifted its position in Molina Healthcare by 1.2% in the second quarter. Comerica Bank now owns 33,159 shares of the company’s stock worth $2,341,000 after purchasing an additional 386 shares during the period. State Board of Administration of Florida Retirement System lifted its position in Molina Healthcare by 86.4% in the second quarter. State Board of Administration of Florida Retirement System now owns 40,338 shares of the company’s stock worth $2,791,000 after purchasing an additional 18,700 shares during the period. Finally, Federated Investors Inc. PA lifted its position in Molina Healthcare by 9.1% in the second quarter. Federated Investors Inc. PA now owns 30,521 shares of the company’s stock worth $2,111,000 after purchasing an additional 2,534 shares during the period. 96.22% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Molina Healthcare (MOH) Earns Neutral Rating from Analysts at Goldman Sachs Group” was posted by Marea Informative and is the property of of Marea Informative. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://www.mareainformativa.com/2018/01/30/molina-healthcare-moh-now-covered-by-analysts-at-goldman-sachs-group-updated-updated-updated.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.